RETRACTION: miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer
- PMID: 38804819
- PMCID: PMC11216918
- DOI: 10.1111/cpr.13681
RETRACTION: miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer
Abstract
L. Wang, B. Li, L. Zhang, Q. Li, Z. He, X. Zhang, X. Huang, Z. Xu, Y. Xia, Q. Zhang, Q. Li, J. Xu, G. Sun, Z. Xu, "miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer," Cell Proliferation 52, no. 3 (2019): e12567, https://doi.org/10.1111/cpr.12567. The above article, published online on 18 March 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Qi Zhou, and John Wiley and Sons Ltd. Following publication, concerns were raised by third parties regarding suspected duplication of figures 2c, 2d, 4g, 4h and 5a. The authors explained that the duplicates were a result of negligence during data storage. Due to the extent and nature of the mistakes made, the editors have lost confidence in the results and conclusions of this study.
© 2024 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.
Retraction of
-
miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer.Cell Prolif. 2019 May;52(3):e12567. doi: 10.1111/cpr.12567. Epub 2019 Mar 18. Cell Prolif. 2019. Retraction in: Cell Prolif. 2024 Jul;57(7):e13681. doi: 10.1111/cpr.13681. PMID: 30883979 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources